A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC)
Awada, A., Bondarenko, I.N., Bonneterre, J., Nowara, E., Ferrero, J.M., Bakshi, A.V., Wilke, C., Piccart, M.
Published in Annals of oncology (01.04.2014)
Published in Annals of oncology (01.04.2014)
Get full text
Journal Article
Fotemustine Compared With Dacarbazine in Patients With Disseminated Malignant Melanoma: A Phase III Study
AVRIL, M. F, AAMDAL, S, PORTA, V. Guillem, FRA, J, BONNETERRE, J, SAÏAG, P, KAMANABROU, D, PEHAMBERGER, H, SUFLIARSKY, J, GONZALEZ LARRIBA, J. L, SCHERRER, A, MENU, Y, GROB, J. J, HAUSCHILD, A, MOHR, P, BONERANDI, J. J, WEICHENTHAL, M, NEUBER, K, BIEBER, T, GILDE, K
Published in Journal of clinical oncology (15.03.2004)
Published in Journal of clinical oncology (15.03.2004)
Get full text
Journal Article
Anastrozole Versus Tamoxifen as First-Line Therapy for Advanced Breast Cancer in 668 Postmenopausal Women: Results of the Tamoxifen or Arimidex Randomized Group Efficacy and Tolerability Study
BONNETERRE, J, THÜRLIMANN, B, ROBERTSON, J. F. R, KRZAKOWSKI, M, MAURIAC, L, KORALEWSKI, P, VERGOTE, I, WEBSTER, A, STEINBERG, M, VON EULER FOR THE ARIMIDEX STUDY GROUP, M
Published in Journal of clinical oncology (15.11.2000)
Published in Journal of clinical oncology (15.11.2000)
Get full text
Journal Article
Third consensus on medical treatment of metastatic breast cancer
Beslija, S., Bonneterre, J., Burstein, H. J., Cocquyt, V., Gnant, M., Heinemann, V., Jassem, J., Köstler, W. J., Krainer, M., Menard, S., Petit, T., Petruzelka, L., Possinger, K., Schmid, P., Stadtmauer, E., Stockler, M., Van Belle, S., Vogel, C., Wilcken, N., Wiltschke, C., Zielinski, C. C., Zwierzina, H.
Published in Annals of oncology (01.11.2009)
Published in Annals of oncology (01.11.2009)
Get full text
Journal Article
A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer
Le Rhun, E., Taillibert, S., Zairi, F., Kotecki, N., Devos, P., Mailliez, A., Servent, V., Vanlemmens, L., Vennin, P., Boulanger, T., Baranzelli, M. C., André, C., Marliot, G., Cazin, J. L., Dubois, F., Assaker, R., Bonneterre, J., Chamberlain, M. C.
Published in Journal of neuro-oncology (01.05.2013)
Published in Journal of neuro-oncology (01.05.2013)
Get full text
Journal Article
Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab
Pierga, J.-Y., Bidard, F.-C., Autret, A., Petit, T., Andre, F., Dalenc, F., Levy, C., Ferrero, J.-M., Romieu, G., Bonneterre, J., Lerebours, F., Bachelot, T., Kerbrat, P., Campone, M., Eymard, J.-C., Mouret-Reynier, M.-A., Gligorov, J., Hardy-Bessard, A.-C., Lortholary, A., Soulie, P., Boher, J.-M., Proudhon, C., Charafe-Jaufret, E., Lemonnier, J., Bertucci, F., Viens, P.
Published in Annals of oncology (01.01.2017)
Published in Annals of oncology (01.01.2017)
Get full text
Journal Article
1941 Is PROSIGNA useful to determine adjuvant treatment in intermediate prognosis early breast cancer (EBC)?
Bonneterre, J, Prat, A, Galvan, P, Giard, S
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
Intra-CSF liposomal cytarabine plus systemic therapy as initial treatment of breast cancer leptomeningeal metastasis: A randomised, open-label trial
Le Rhun, E., Mailliez, A., Wallet, J., Rodrigues, I., Boulanger, T., Desmoulins, I., Barriere, J., Fabbro, M., Taillibert, S., Andre, C., Le Deley, M.C., Weller, M., Bonneterre, J.M.
Published in Annals of oncology (01.10.2018)
Published in Annals of oncology (01.10.2018)
Get full text
Journal Article
The sequential use of endocrine treatment for advanced breast cancer: where are we?
Barrios, C., Forbes, J.F., Jonat, W., Conte, P., Gradishar, W., Buzdar, A., Gelmon, K., Gnant, M., Bonneterre, J., Toi, M., Hudis, C., Robertson, J.F.R.
Published in Annals of oncology (01.06.2012)
Published in Annals of oncology (01.06.2012)
Get full text
Journal Article
Docetaxel vs 5-fluorouracil plus vinorelbine in metastatic breast cancer after anthracycline therapy failure
BONNETERRE, J, ROCHE, H, MONNIER, A, GUASTALLA, J. P, NAMER, M, FARGEOT, P, ASSADOURIAN, S
Published in British journal of cancer (18.11.2002)
Published in British journal of cancer (18.11.2002)
Get full text
Journal Article
Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients
MAILLIEZ, A, BALDINI, C, VAN, J. T, SERVENT, V, MALLET, Y, BONNETERRE, J
Published in British journal of cancer (07.09.2010)
Published in British journal of cancer (07.09.2010)
Get full text
Journal Article
Anastrozole (Arimidex™) versus tamoxifen as first-line therapy for advanced breast cancer in postmenopausal women: survival analysis and updated safety results
Nabholtz, J.M, Bonneterre, J, Buzdar, A, Robertson, J.F.R, Thürlimann, B
Published in European journal of cancer (1990) (01.08.2003)
Published in European journal of cancer (1990) (01.08.2003)
Get full text
Journal Article
Pharmacokinetic evaluation of the vinorelbine–lapatinib combination in the treatment of breast cancer patients
Rezai, Keyvan, Urien, S., Isambert, N., Roche, H., Dieras, V., Berille, J., Bonneterre, J., Brain, E., Lokiec, F.
Published in Cancer chemotherapy and pharmacology (01.12.2011)
Published in Cancer chemotherapy and pharmacology (01.12.2011)
Get full text
Journal Article
ERBB2 oncogene in human breast cancer and its clinical significance
Get full text
Book Review
Journal Article